Writing Chemistry Patents and Intellectual Property: A Practical Guide

Writing Chemistry Patents and Intellectual Property: A Practical Guide
Writing Chemistry Patents and Intellectual Property: A Practical Guide

Intellectual property is constantly at risk, and the protection of chemical science and technology through the patenting process allows individuals and companies to protect their hard work. But in order to truly be able to protect your ideas, you need to understand the basics of patenting for yourself. A practical handbook designed to empower inventors like you to write your own patent application drafts in conjunction with an attorney, Writing Chemistry Patents and Intellectual Property: A Practical Guide presents a brand new methodology for success.
The book teaches you how to structure a literature search, to educate the patent examiner on your work, to prepare an application that can be easily duplicated, and to understand what goes on behind the scenes during the patent examiner's rejection process. Providing essential insights, invaluable strategies, and applicable, real-world examples designed to maximize the chances that a patent will be accepted by the United States Patent and Trademark Office, Writing Chemistry Patents and Intellectual Property is the book you need if you want to keep your work protected.


Writing Chemistry Patents and Intellectual Property
Francis J. Waller
John Wiley & Sons
Price: 71.90 Euro
ISBN: 978-0-470-49740-1

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.